GlaxoSmithKline PLC — Director's Dealing 2016

Jan 4, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7694K

GlaxoSmithKline PLC

04 January 2016

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares ('ADSs') of GlaxoSmithKline plc (the 'Company').

On 31 December 2015, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £13.83 per Ordinary Share, and notional ADSs at a price of $40.98 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2015 to 31 December 2015:

Non Executive Director	Ordinary Shares	No. of ADSs
Sir Philip Hampton	3,163.413
Professor Sir Roy Anderson	655.278
Vindi Banga	1,536.515
Dr Stephanie Burns		410.403
Stacey Cartwright	519.704
Lynn  Elsenhans		912.543
Judy Lewent		398.332
Sir Deryck Maughan		1,110.502
Dr Daniel Podolsky		832.877
Urs Rohner	610.087
Hans Wijers	519.704

In addition, on 31 December 2015, Mr Banga was allocated 566.213 notional Ordinary Shares at a price of £12.51 per Ordinary Share in respect of the period of service from 1 September 2015 to 30 September 2015.

The Company and the Non-Executive Directors were informed of these allocations on 4 January 2016.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

4 January 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSEZLFBQFFEBBL